Home Newsfeeds Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18

Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18

Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $22 to $18.

byBenzinga Newsdesk

July 15, 2022

1 minute read

Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $22 to $18.

Analyst Ratings

What 22 Analyst Ratings Have To Say About Global Payments

By Benzinga Insights

October 20, 5:00 PM

Over the past 3 months, 22 analysts have published their opinion on Global Payments (NYSE:GPN) stock. These analysts…

GPN

Fear & Greed Index Drops But Remains In ‘Neutral’ Zone

By Lisa Levin

August 31, 6:44 AM

The CNN Money Fear and Greed index remained in the "neutral" zone, but moved lower following another drop in the US stocks on Tuesday. Each of the 11 S&P 500 sectors closed in negative zone, with the energy sector dropping around 3.4%, as crude oil prices dipped more than 5% on Tuesday.

AAPL

Reach For The Stars: Accenture And Open Cosmos Team Up To Tackle Sustainability With Satellite Data

By Lekha Gupta

September 11, 5:57 AM

Accenture PLC (NYSE: ACN) disclosed an investment and partnership with Open Cosmos

ACN

Hudbay Minerals Q3 EPS $(0.05) Beats $(0.06) Estimate

By Benzinga Newsdesk

November 3, 1:17 AM

Hudbay Minerals (NYSE:HBM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.06) by 16.67 percent. This is a 133.33 percent decrease over earnings of $0.15 per share from the

HBM

Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $18

Related Posts

What 22 Analyst Ratings Have To Say About Global Payments

Fear & Greed Index Drops But Remains In ‘Neutral’ Zone

Reach For The Stars: Accenture And Open Cosmos Team Up To Tackle Sustainability With Satellite Data

Hudbay Minerals Q3 EPS $(0.05) Beats $(0.06) Estimate